Skip to content
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filings
Company
Our Team
Governance
ESG
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filings
Company
Our Team
Governance
ESG
Search
Press Releases
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals
March 26, 2020
Read More →
IGC Reports Financial Results for the Quarter Ended December 31st, 2019
February 11, 2020
Read More →
IGC Reports Financial Results for the Quarter Ended September 30, 2019
November 6, 2019
Read More →
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 Study
September 19, 2019
Read More →
IGC Reports Financial Results for the Quarter Ended June 30, 2019
August 8, 2019
Read More →
IGC to Participate in Arizona’s Industrial Hemp Program
June 14, 2019
Read More →
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019
June 14, 2019
Read More →
IGC Provides Corporate Updates
March 26, 2019
Read More →
